Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (15)

2022

  1. Human Stem Cell Transplantation for Retinal Degenerative Diseases: Where Are We Now?

    Medicina (Lithuania), Vol. 58, Núm. 1

2021

  1. Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases

    International Ophthalmology, Vol. 41, Núm. 7, pp. 2347-2358

2020

  1. Potential Effect of Plasma Rich in Growth Factors-Endoret in Stromal Wound Healing in Additive Surgery

    Ophthalmic Research, Vol. 63, Núm. 2, pp. 203-212

2019

  1. Role of corneal nerves in ocular surface homeostasis and disease

    Acta Ophthalmologica, Vol. 97, Núm. 2, pp. 137-145

2018

  1. Controlled Adverse Environment Chambers in Dry Eye Research

    Current Eye Research, Vol. 43, Núm. 4, pp. 445-450

  2. Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)

    PLoS ONE, Vol. 13, Núm. 10

  3. Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

    International Medical Case Reports Journal, Vol. 11, pp. 97-103

  4. Plasma rich in growth factors for the treatment of dry eye after LASIK surgery

    Ophthalmic Research, Vol. 60, Núm. 2, pp. 80-86

  5. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

    Medicine (United States), Vol. 97, Núm. 17

  6. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops

    International Ophthalmology, Vol. 38, Núm. 3, pp. 1193-1204

2017

  1. Allogeneic blood-based therapies: Hype or hope?

    Eye (Basingstoke)

  2. Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology

    Ocular Surface, Vol. 15, Núm. 2, pp. 248-256

  3. Regenerative therapies in dry eye disease: From growth factors to cell therapy

    International Journal of Molecular Sciences, Vol. 18, Núm. 11

  4. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 391-399

2016

  1. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model

    Experimental Eye Research, Vol. 151, pp. 115-121